Michelle Petri, MD MPH

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    AstraZeneca
    Topic:
    SLE
    Date added:
    01/21/2024
    Date updated:
    01/21/2024
    Relationship end date:
    10/31/2022
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Aurinia
    Topic:
    SLE
    Date added:
    01/21/2024
    Date updated:
    01/21/2024
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Eli Lilly
    Topic:
    SLE
    Date added:
    01/21/2024
    Date updated:
    01/21/2024
    Relationship end date:
    12/31/2023
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Exagen
    Topic:
    SLE
    Date added:
    01/21/2024
    Date updated:
    01/21/2024
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    GSK
    Topic:
    SLE
    Date added:
    01/21/2024
    Date updated:
    01/21/2024
    Relationship end date:
    10/31/2023
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Janssen
    Topic:
    SLE
    Date added:
    01/21/2024
    Date updated:
    01/21/2024
  • Attribution:
    Self
    Type of financial relationship:
    Consulting Fee
    Ineligible company:
    Amgen
    Topic:
    SLE
    Date added:
    01/21/2024
    Date updated:
    01/21/2024
    Relationship end date:
    04/30/2023
  • Attribution:
    Self
    Type of financial relationship:
    Consulting Fee
    Ineligible company:
    AnaptysBio
    Topic:
    SLE
    Date added:
    01/21/2024
    Date updated:
    01/21/2024
    Relationship end date:
    01/31/2023
  • Attribution:
    Self
    Type of financial relationship:
    Consulting Fee
    Ineligible company:
    Annexon Bio
    Topic:
    SLE
    Date added:
    01/21/2024
    Date updated:
    01/21/2024
  • Attribution:
    Self
    Type of financial relationship:
    Consulting Fee
    Ineligible company:
    Argenx
    Topic:
    SLE
    Date added:
    01/21/2024
    Date updated:
    01/21/2024

Pages

Return to 2024 Inova Fairfax MGR (Enduring Material): Update on SLE Classification, Treatment, and Complications